FDA expands XENOVIEW(R) indication to include children from six years of age
(LSE:POLX), DURHAM, NC and LONDON, June 02, 2025 (GLOBE NEWSWIRE) — Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (“MRI”) of the lungs, announces that the US Food and Drug Administration (“FDA”) has approved the Company's Supplemental New Drug Application (“NDA”) to expand […]